Biocorp

Report Publication Announcement • Jan 6, 2021

BIOCORP: 2021 financial calendar

Issoire, France, January 6th, 2021, 06h00 pm CET – BIOCORP (FR0012788065 – ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, updates its financial reporting schedule for 2020* :

Annonce	Date*
2020 full-year results	8th, 2021 Thursday, April Before the market opening
Annual shareholders meeting	7th, Friday, May 2021
2020 first-half results	Thursday, September 23rd, 2021 Before the market opening

* This schedule is indicative and subject to change.

À PROPOS DE BIOCORP

Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale since late 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 63 employees.

BIOCORP is listed on Alternext since July 2015 (FR0012788065 – ALCOR). For more information, please visit www.biocorpsys.com Follow us on Twitter @BIOCORPSystems

BIOCORP CONTACTS

Jacques Gardette Éric Dessertenne Sylvaine Dessard investisseurs@biocorp.fr rp@biocorp.fr

Chairman of the Board CEO Marketing @ Communication Director + 33 (0)6 88 69 72 85

ULYSSE COMMUNICATION CONTACTS Bruno ARABIAN Nicolas DANIELS barabian@ulysse-communication.com ndaniels@ulysse-communication.com +33 (0)6 87 88 46 26 +33 (0)6 63 66 59 22